Literature DB >> 6408426

Two routes for producing human insulin utilizing recombinant DNA technology.

B H Frank, R E Chance.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6408426

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN： 0341-3098


× No keyword cloud information.
  4 in total

1.  Design and folding of [GluA4(ObetaThrB30)]insulin ("ester insulin"): a minimal proinsulin surrogate that can be chemically converted into human insulin.

Authors:  Youhei Sohma; Qing-Xin Hua; Jonathan Whittaker; Michael A Weiss; Stephen B H Kent
Journal:  Angew Chem Int Ed Engl       Date:  2010-07-26       Impact factor: 15.336

2.  Biomimetic synthesis of lispro insulin via a chemically synthesized "mini-proinsulin" prepared by oxime-forming ligation.

Authors:  Youhei Sohma; Stephen B H Kent
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

3.  Crystal structure of a "nonfoldable" insulin: impaired folding efficiency despite native activity.

Authors:  Ming Liu; Zhu-Li Wan; Ying-Chi Chu; Hassan Aladdin; Birgit Klaproth; Meredith Choquette; Qing-Xin Hua; Robert B Mackin; J Sunil Rao; Pierre De Meyts; Panayotis G Katsoyannis; Peter Arvan; Michael A Weiss
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

Review 4.  Equivalent Recombinant Human Insulin Preparations and their Place in Therapy.

Authors:  Juergen Sandow; Wolfgang Landgraf; Reinhard Becker; Gerhard Seipke
Journal:  Eur Endocrinol       Date:  2015-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.